Cat: IPD-X24638

Recombinant Human Alpha-crystallin A chain/CRYAA Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    Alpha-crystallin A chain/CRYAA

  • 简介

    Alpha-crystallin A chain/CRYAA Protein, Human (His) is a recombinant Alpha-crystallin A chain protein with a His tag. Alpha-crystallin A chain/CRYAA is a small heat shock protein and molecular chaperone that prevents nonspecific aggregation of denaturing proteins. Several point mutations in the alphaA-crystallin gene cause congenital human cataracts by unknown mechanisms[1].

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Biological Activity

    Measured by its binding ability in a functional ELISA. When Recombinant CRYAA Human is used at 2 μg/mL can bind anti-CRYAA antibody. The ED50 for this effect is 1.405 μg/mL. Measured by its binding ability in a functional ELISA. When Recombinant CRYAA Human is used at 2 μg/mL can bind anti-CRYAA antibody. The ED50 for this effect is 1.405 μg/mL.

  • Alternative Names

    rHuAlpha-crystallin A chain/CRYAA, His; Alpha-Crystallin A Chain; Heat Shock Protein Beta-4; HspB4; Alpha-Crystallin A Chain; Short Form; CRYAA; CRYA1; HSPB4

  • Species

    Human

  • Source

    E. coli

  • Tag

    C-6*His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    P02489

  • Expression Region

    M1-S173

  • Protein Length

    Full Length

  • Molecular Weight

    20-23 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Alpha-crystallin A chain (CRYAA) is a crucial component of the eye lens, playing a vital role in maintaining lens transparency and preventing protein aggregation, which is essential for proper vision. CRYAA belongs to the small heat shock protein family, exhibiting chaperone-like properties that help protect cellular proteins from stress-induced damage. Research on the recombinant form of CRYAA has gained significance due to its potential therapeutic applications in ocular diseases, particularly cataract formation, which remains a leading cause of blindness globally. The ability to produce recombinant CRYAA allows for detailed structural and functional studies, enabling scientists to understand its protective mechanisms at a molecular level. Furthermore, studies have indicated that CRYAA might have implications beyond the lens, influencing cellular stress responses and playing a role in various pathological conditions, including neurodegenerative diseases. The exploration of CRYAA's functions through recombinant protein allows for innovative approaches to drug development and the design of novel therapies aimed at enhancing visual health and overall protein homeostasis. This research highlights the importance of CRYAA as a multi-functional protein, bridging gaps between basic and clinical science, ultimately paving the way for advancements in treatments for eye disorders and age-related conditions, thus improving patient outcomes.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US